BSEBoard Meeting4d ago · 31 Jul 2026, 12:40 pm

Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Quarterly Results For The Quarter ....

Marksans Pharma Ltd · 524404

✦ AI SummaryResults

Marksans Pharma Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve Quarterly Results For The Quarter Ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Board Meeting Intimation For Declaration Of Quarterly Results For The Quarter Ended June 30, 2026

Attachments (1)

📄

5dc8f8f6-ee66-4a5d-8c66-13379ab43bc1.pdf

pdf

Download →
View document text
Date: July 31, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Intimation of Board Meeting Dear Sir/Madam, Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and other regulations, if applicable, we hereby inform the exchanges that a meeting of the Board of Directors of the Company will be held on Wednesday, August 12, 2026 at Mumbai, inter alia, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended June 30, 2026. Kindly note that as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code on Prohibition of Insider Trading, the Trading Window for dealing in Company’s shares has been closed for the Company’s Designated Persons (including Directors) and their immediate relatives from July 1, 2026 and will remain closed till Forty-Eight hours after the announcement of the Financial Results i.e. up to August 14, 2026 (both days inclusive). Further, as per the Listing Regulations, this intimation of the Board Meeting would be available on the website of the Company i.e. www.marksanspharma.com, BSE Limited i.e. www.bseindia.com and National Stock Exchange of India Limited i.e. www.nseindia.com. We request you to take the aforesaid on records. Thanking you. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com